Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 9 | 2017 | 805 | 1.710 |
Why?
|
| Fragile X Syndrome | 3 | 2017 | 148 | 1.300 |
Why?
|
| rac1 GTP-Binding Protein | 5 | 2017 | 64 | 1.130 |
Why?
|
| Multiple Sclerosis | 11 | 2003 | 390 | 0.860 |
Why?
|
| rac GTP-Binding Proteins | 3 | 2011 | 24 | 0.850 |
Why?
|
| Actins | 2 | 2017 | 317 | 0.840 |
Why?
|
| Fear | 5 | 2017 | 198 | 0.820 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2009 | 133 | 0.760 |
Why?
|
| Synapses | 4 | 2013 | 445 | 0.700 |
Why?
|
| Myelin Basic Protein | 10 | 2003 | 68 | 0.700 |
Why?
|
| Cell Membrane | 2 | 2017 | 464 | 0.650 |
Why?
|
| Long-Term Potentiation | 4 | 2017 | 105 | 0.550 |
Why?
|
| Lactobacillus | 4 | 1999 | 42 | 0.490 |
Why?
|
| Learning | 2 | 2017 | 369 | 0.480 |
Why?
|
| Streptococcus | 4 | 1999 | 63 | 0.480 |
Why?
|
| Bifidobacterium | 4 | 1999 | 66 | 0.470 |
Why?
|
| T-Lymphocytes | 12 | 2003 | 1775 | 0.450 |
Why?
|
| Cytokines | 9 | 2003 | 1347 | 0.450 |
Why?
|
| Brain | 5 | 2015 | 3234 | 0.440 |
Why?
|
| Neuronal Plasticity | 3 | 2013 | 288 | 0.430 |
Why?
|
| Herpesvirus 6, Human | 3 | 2003 | 54 | 0.410 |
Why?
|
| Memory | 5 | 2017 | 358 | 0.400 |
Why?
|
| Brain Diseases | 1 | 2015 | 305 | 0.380 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 354 | 0.370 |
Why?
|
| Dendritic Spines | 1 | 2011 | 57 | 0.340 |
Why?
|
| Neuropeptides | 1 | 2011 | 111 | 0.330 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 489 | 0.320 |
Why?
|
| Dizocilpine Maleate | 1 | 2009 | 16 | 0.320 |
Why?
|
| Dendrites | 1 | 2011 | 181 | 0.310 |
Why?
|
| Aminoquinolines | 3 | 2017 | 36 | 0.310 |
Why?
|
| Cognition | 1 | 2015 | 842 | 0.310 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 743 | 0.290 |
Why?
|
| Cell Fractionation | 2 | 2006 | 23 | 0.290 |
Why?
|
| Anxiety | 2 | 2013 | 1001 | 0.290 |
Why?
|
| Cognition Disorders | 1 | 2013 | 565 | 0.290 |
Why?
|
| Probiotics | 3 | 1999 | 231 | 0.270 |
Why?
|
| Animals | 19 | 2017 | 34321 | 0.270 |
Why?
|
| Theta Rhythm | 2 | 2017 | 24 | 0.270 |
Why?
|
| Mice | 14 | 2013 | 18465 | 0.260 |
Why?
|
| Mental Disorders | 1 | 2015 | 900 | 0.260 |
Why?
|
| Association Learning | 1 | 2007 | 24 | 0.260 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 1226 | 0.250 |
Why?
|
| Avoidance Learning | 1 | 2007 | 63 | 0.250 |
Why?
|
| Synaptic Membranes | 1 | 2006 | 23 | 0.250 |
Why?
|
| Synaptosomes | 1 | 2006 | 28 | 0.250 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 30 | 0.240 |
Why?
|
| Pyrimidines | 3 | 2017 | 443 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 7 | 2011 | 4762 | 0.240 |
Why?
|
| Roseolovirus Infections | 2 | 2003 | 30 | 0.240 |
Why?
|
| Protein Transport | 1 | 2006 | 362 | 0.220 |
Why?
|
| NADPH Oxidases | 1 | 2005 | 108 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2017 | 3861 | 0.220 |
Why?
|
| Myelin Proteolipid Protein | 2 | 2001 | 27 | 0.210 |
Why?
|
| Transcription Factors | 1 | 2013 | 2436 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 4684 | 0.200 |
Why?
|
| Oligodendroglia | 1 | 2002 | 80 | 0.180 |
Why?
|
| Cytosol | 2 | 2017 | 140 | 0.180 |
Why?
|
| Neurogenesis | 2 | 2015 | 224 | 0.180 |
Why?
|
| Myelin Sheath | 1 | 2002 | 127 | 0.180 |
Why?
|
| Leukocytes | 2 | 1999 | 211 | 0.170 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2011 | 102 | 0.170 |
Why?
|
| DNA, Viral | 1 | 2002 | 451 | 0.170 |
Why?
|
| Autoimmunity | 2 | 2001 | 181 | 0.170 |
Why?
|
| Analysis of Variance | 4 | 2011 | 954 | 0.160 |
Why?
|
| Glycoproteins | 1 | 2002 | 344 | 0.160 |
Why?
|
| Viral Proteins | 1 | 2002 | 339 | 0.160 |
Why?
|
| Autoantibodies | 2 | 2002 | 465 | 0.160 |
Why?
|
| In Vitro Techniques | 4 | 2011 | 824 | 0.160 |
Why?
|
| Antibodies, Viral | 3 | 2003 | 1169 | 0.160 |
Why?
|
| Nitric Oxide | 2 | 1999 | 465 | 0.160 |
Why?
|
| Cell Line | 8 | 2003 | 2603 | 0.150 |
Why?
|
| Lactobacillus acidophilus | 1 | 1999 | 2 | 0.150 |
Why?
|
| Yogurt | 1 | 1999 | 13 | 0.150 |
Why?
|
| Cholera Toxin | 1 | 1999 | 43 | 0.150 |
Why?
|
| Ergosterol | 1 | 1998 | 2 | 0.150 |
Why?
|
| Freund's Adjuvant | 1 | 1998 | 26 | 0.140 |
Why?
|
| Immunoglobulins | 1 | 1999 | 159 | 0.140 |
Why?
|
| Macrophages | 2 | 1999 | 663 | 0.140 |
Why?
|
| Immunoglobulin A | 1 | 1999 | 210 | 0.140 |
Why?
|
| Reflex, Acoustic | 1 | 2017 | 3 | 0.140 |
Why?
|
| Prepulse Inhibition | 1 | 2017 | 3 | 0.140 |
Why?
|
| Reflex, Startle | 1 | 2017 | 34 | 0.140 |
Why?
|
| Exploratory Behavior | 3 | 2013 | 53 | 0.130 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 56 | 0.130 |
Why?
|
| Antibodies | 1 | 1998 | 357 | 0.130 |
Why?
|
| Male | 16 | 2017 | 65110 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2006 | 2970 | 0.120 |
Why?
|
| Neurons | 3 | 2011 | 1990 | 0.120 |
Why?
|
| Maze Learning | 2 | 2013 | 99 | 0.110 |
Why?
|
| Pain | 1 | 2017 | 439 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2000 | 2567 | 0.100 |
Why?
|
| Peptide Fragments | 4 | 2001 | 781 | 0.100 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2013 | 13 | 0.100 |
Why?
|
| Conditioning, Operant | 1 | 2013 | 17 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2002 | 2561 | 0.100 |
Why?
|
| Molecular Sequence Data | 6 | 2002 | 3613 | 0.090 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2013 | 71 | 0.090 |
Why?
|
| Time Factors | 3 | 2011 | 6272 | 0.090 |
Why?
|
| Silver Staining | 1 | 2011 | 5 | 0.090 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2011 | 34 | 0.090 |
Why?
|
| Pyrones | 1 | 2011 | 6 | 0.090 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2011 | 28 | 0.090 |
Why?
|
| Interferon-beta | 2 | 2002 | 56 | 0.090 |
Why?
|
| Vaccination | 3 | 2002 | 1040 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2011 | 95 | 0.080 |
Why?
|
| Female | 14 | 2017 | 71032 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 279 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2011 | 249 | 0.080 |
Why?
|
| Immunodominant Epitopes | 2 | 2001 | 53 | 0.080 |
Why?
|
| Quinolines | 1 | 2011 | 120 | 0.080 |
Why?
|
| Behavior, Animal | 2 | 2009 | 510 | 0.080 |
Why?
|
| Th1 Cells | 2 | 2000 | 156 | 0.080 |
Why?
|
| Schizophrenic Psychology | 1 | 2009 | 83 | 0.070 |
Why?
|
| Raptors | 1 | 2008 | 6 | 0.070 |
Why?
|
| Th2 Cells | 2 | 2000 | 186 | 0.070 |
Why?
|
| Epitopes | 2 | 2001 | 432 | 0.070 |
Why?
|
| Humans | 17 | 2017 | 131406 | 0.070 |
Why?
|
| Digestive System | 2 | 1999 | 61 | 0.070 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2008 | 21 | 0.070 |
Why?
|
| Exercise Test | 1 | 2010 | 243 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2008 | 322 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2011 | 4666 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 579 | 0.060 |
Why?
|
| Centrifugation | 1 | 2006 | 18 | 0.060 |
Why?
|
| Peptides | 2 | 2001 | 835 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2009 | 331 | 0.060 |
Why?
|
| Environment | 1 | 2007 | 149 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 134 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1024 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 2363 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 2354 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 366 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 2005 | 21 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 88 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 804 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 144 | 0.060 |
Why?
|
| Superoxides | 1 | 2005 | 129 | 0.060 |
Why?
|
| Antibody Formation | 2 | 2002 | 266 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2003 | 335 | 0.050 |
Why?
|
| Biological Transport | 1 | 2005 | 333 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2006 | 1018 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2002 | 120 | 0.050 |
Why?
|
| Middle Aged | 7 | 2003 | 28808 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2002 | 236 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2000 | 57 | 0.050 |
Why?
|
| Adult | 7 | 2003 | 31629 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2003 | 23 | 0.050 |
Why?
|
| Autoantigens | 1 | 2003 | 104 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2003 | 187 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 60 | 0.050 |
Why?
|
| Virion | 1 | 2002 | 116 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2000 | 201 | 0.040 |
Why?
|
| HLA-DR2 Antigen | 1 | 2001 | 6 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1610 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2000 | 52 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2001 | 118 | 0.040 |
Why?
|
| Herpesviridae Infections | 1 | 2002 | 139 | 0.040 |
Why?
|
| Erythroid Precursor Cells | 1 | 2000 | 21 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2000 | 42 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 2000 | 65 | 0.040 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2000 | 10 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2000 | 30 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2001 | 280 | 0.040 |
Why?
|
| Chemokine CCL5 | 1 | 2000 | 53 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 2000 | 57 | 0.040 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2000 | 47 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 1123 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 791 | 0.040 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1999 | 5 | 0.040 |
Why?
|
| Clone Cells | 4 | 2001 | 171 | 0.040 |
Why?
|
| Cell Wall | 1 | 1999 | 42 | 0.040 |
Why?
|
| Hot Temperature | 1 | 1999 | 144 | 0.040 |
Why?
|
| Lymphatic System | 1 | 1999 | 19 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 108 | 0.040 |
Why?
|
| Ascitic Fluid | 1 | 1999 | 29 | 0.040 |
Why?
|
| Peyer's Patches | 1 | 1999 | 17 | 0.040 |
Why?
|
| Polymyxin B | 1 | 1999 | 48 | 0.040 |
Why?
|
| Cold Temperature | 1 | 1999 | 81 | 0.040 |
Why?
|
| Cytoplasm | 1 | 1999 | 253 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 1999 | 90 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 225 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2000 | 393 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1999 | 199 | 0.040 |
Why?
|
| Spleen | 1 | 1999 | 256 | 0.030 |
Why?
|
| Immunization | 1 | 1999 | 307 | 0.030 |
Why?
|
| Rabbits | 1 | 1998 | 633 | 0.030 |
Why?
|
| Cell Movement | 1 | 2000 | 875 | 0.030 |
Why?
|
| Eating | 1 | 1999 | 379 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 566 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2002 | 812 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1999 | 600 | 0.030 |
Why?
|
| Stem Cells | 1 | 2001 | 712 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2001 | 132 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 1487 | 0.030 |
Why?
|
| Feces | 1 | 1999 | 725 | 0.030 |
Why?
|
| Body Weight | 1 | 1999 | 986 | 0.030 |
Why?
|
| Lymphocyte Activation | 3 | 2001 | 680 | 0.030 |
Why?
|
| Aged | 2 | 2001 | 21216 | 0.020 |
Why?
|
| Buthionine Sulfoximine | 1 | 2010 | 9 | 0.020 |
Why?
|
| Dinoprost | 1 | 2010 | 25 | 0.020 |
Why?
|
| Cyclic N-Oxides | 1 | 2010 | 18 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 99 | 0.020 |
Why?
|
| Adaptation, Ocular | 1 | 2010 | 18 | 0.020 |
Why?
|
| Spin Labels | 1 | 2010 | 25 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2010 | 49 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 86 | 0.020 |
Why?
|
| Glutathione | 1 | 2010 | 197 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 161 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 741 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 138 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1148 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2000 | 642 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 329 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 428 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 1569 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1390 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 3454 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 213 | 0.010 |
Why?
|
| Dimerization | 1 | 2001 | 139 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 195 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2000 | 95 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 2000 | 13 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 2000 | 17 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2000 | 160 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2000 | 132 | 0.010 |
Why?
|
| Interferon beta-1a | 1 | 2000 | 23 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 220 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2000 | 145 | 0.010 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 1999 | 12 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2000 | 226 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 291 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 1999 | 8 | 0.010 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1999 | 6 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1999 | 15 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1999 | 71 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2000 | 185 | 0.010 |
Why?
|
| Virus Replication | 1 | 2002 | 597 | 0.010 |
Why?
|
| Alanine | 1 | 1999 | 163 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 609 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 588 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 410 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 785 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2000 | 542 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 357 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2000 | 529 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 1450 | 0.010 |
Why?
|
| Protein Binding | 1 | 2001 | 1710 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1998 | 414 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 2204 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 2782 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 2984 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2002 | 12923 | 0.000 |
Why?
|